Special Section

Focus on Psychosis

The objective of the Focus on Psychosis section is to promote scientific research that impacts the clinical care of individuals with psychotic disorders and related conditions. Topics may pertain to conditions across the continuum of psychosis (eg, disorders in the schizophrenia spectrum or psychosis in mood and other psychiatric disorders) and at any stage of illness (eg, high-risk, first-episode, chronic, and in recovery). We are especially interested in high-quality manuscripts describing well-designed and well-conducted studies relating to pharmacologic, somatic, psychosocial, cognitive, and complementary therapies. While basic and translational research studies in psychosis are not the focus of the journal, we strongly welcome studies that incorporate biological measures as a clinical outcome and/or that elucidate biological mechanisms associated with specific clinical outcomes.

Section Editor

Ann K. Shinn, MD, MPH

Contact:
[email protected]

Learn more about Dr Shinn

Submit a Paper

for consideration in the Focus on Psychosis section

Learn How to Submit

JCP
Aripiprazole Lauroxil Initiation Regimens
JCP
Emotional Neglect and Inflammatory Ratios in First-Episode Psychosis
JCP
Concomitant LAIs and Time to Rehospitalization in Patients Receiving Clozapine
JCP
Clozapine Use and Specific Indications
JCP
Severity of Antipsychotic-Induced Cervical Dystonia by Algorithm-Based Rating System
JCP
Excess Mortality Associated With Schizophrenia
JCP
Inflammatory Features in Prodromal Psychosis
JCP
Generalizability of RCTs in First-Episode Schizophrenia
JCP
Neighborhood Vulnerability in First-Episode Psychosis
JCP
Predictors for Initiation of LAIs in Individuals With Early-Phase Schizophrenia
JCP
Antipsychotic Dose and Weight Gain
JCP
Telehealth of CSC in Early Psychosis During COVID-19